
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 155
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 155
Showing 1-25 of 155 citing articles:
Metabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 59
Jhan-Jie Peng, Limei Wang, Zhiyu Li, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 59
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
100 years of the Warburg effect: A cancer metabolism endeavor
Sarah‐Maria Fendt
Cell (2024) Vol. 187, Iss. 15, pp. 3824-3828
Closed Access | Times Cited: 30
Sarah‐Maria Fendt
Cell (2024) Vol. 187, Iss. 15, pp. 3824-3828
Closed Access | Times Cited: 30
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 5
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 5
Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells
Chuwen Li, Haiyan Guo, Peisong Zhai, et al.
Cancer Research (2023) Vol. 84, Iss. 2, pp. 258-275
Open Access | Times Cited: 31
Chuwen Li, Haiyan Guo, Peisong Zhai, et al.
Cancer Research (2023) Vol. 84, Iss. 2, pp. 258-275
Open Access | Times Cited: 31
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 23
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 23
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy
Caterina Scirgolea, Rosa Sottile, Marco De Luca, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1845-1857
Closed Access | Times Cited: 11
Caterina Scirgolea, Rosa Sottile, Marco De Luca, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1845-1857
Closed Access | Times Cited: 11
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
Tianye Li, Weijiang Zhang, Mengke Niu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Tianye Li, Weijiang Zhang, Mengke Niu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Caihong Li, Dongkai Cheng, Peng Li
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Caihong Li, Dongkai Cheng, Peng Li
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Navigating the Brain: Harnessing Endogenous Cellular Hitchhiking for Targeting Neoplastic and Neuroinflammatory Diseases
Suraj Wagh, Paras Famta, Saurabh Shah, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101040-101040
Open Access | Times Cited: 1
Suraj Wagh, Paras Famta, Saurabh Shah, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101040-101040
Open Access | Times Cited: 1
Bio-responsive Au-miR-183 inhibitor enhances immunotherapy in hepatocellular carcinoma by inducing immunogenic cell death
Liang Yin, Yu Wei, Ya Liu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 498-517
Open Access | Times Cited: 6
Liang Yin, Yu Wei, Ya Liu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 498-517
Open Access | Times Cited: 6
HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer
Zhenyu Li, Ran Wei, S. Yao, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24664-e24664
Open Access | Times Cited: 5
Zhenyu Li, Ran Wei, S. Yao, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24664-e24664
Open Access | Times Cited: 5
Ultrasound-responsive metal–organic framework-based nanosystem for sonodynamic therapy/amplified ferroptosis/IDO-blockade osteosarcoma immunotherapy
Qingjian Lei, Wei Zhou, Shijie Gao, et al.
Chemical Engineering Journal (2024) Vol. 490, pp. 151614-151614
Closed Access | Times Cited: 5
Qingjian Lei, Wei Zhou, Shijie Gao, et al.
Chemical Engineering Journal (2024) Vol. 490, pp. 151614-151614
Closed Access | Times Cited: 5
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
Yajing Qiu, Yapeng Su, Ermei Xie, et al.
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 103-121.e8
Closed Access | Times Cited: 5
Yajing Qiu, Yapeng Su, Ermei Xie, et al.
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 103-121.e8
Closed Access | Times Cited: 5
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+T cell infiltration and functional transition
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007230-e007230
Open Access | Times Cited: 11
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007230-e007230
Open Access | Times Cited: 11
1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis
Lei Chang, Guohao Li, Shan Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Lei Chang, Guohao Li, Shan Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4